Response to 'Inclusion of Placebos and Blinding for Ascending Dose First‐in‐Human Studies and Other Underpowered Phase 1 studies has not been Justified and on Balance is Not Useful' by D.A. Parasrampuria and L.Z. Benet. Issue 6 (14th September 2015)